Sample characteristics.

<p>Notes: AIS, ASIA Impairment Scale.</p><p>The data are means (SD) for quantitative variables and percentages for qualitative variables.</p><p>*, years</p><p>†, %</p><p>‡, mg/dL</p><p>Sample characteristics.</p

Differences in serum lipids classified according to detailed neurological level of injury.

<p>Notes: All data shown are adjusted differences in a regression model including motor grade (AIS A-B vs. C-E), neurological lesion level (cervical vs. thoracic vs. lumbo-sacral), age, and sex.</p><p>*, mg/dL.</p><p>Differences in serum lipids classified according to detailed neurological level of injury.</p

Differences in serum lipids classified according to motor grade and neurological level of injury.

<p>Notes: AIS, ASIA Impairment Scale.</p><p>All data shown are adjusted differences (95%CI) in a regression model including motor grade (AIS A-B vs. C-E), neurological level of injury (proximal [upper limb involvement] vs. distal [only lower limb involvement]), age, and sex.</p><p>*, mg/dL</p><p>Differences in serum lipids classified according to motor grade and neurological level of injury.</p

Differences in serum lipids classified according to a combined classification of motor grade and neurological level of injury.

<p>Notes: AIS, ASIA Impairment Scale.</p><p>All data shown are adjusted differences in a regression model including the combined motor grade and neurological lesion level, age, and sex.</p><p>*, mg/dL.</p><p>Differences in serum lipids classified according to a combined classification of motor grade and neurological level of injury.</p

Hematological results from primary blood samples (n = 10) that were used to derive blood preparations.

<p>Hematological results from primary blood samples (n = 10) that were used to derive blood preparations.</p

Scatter plot of the change of mtDNAcn(WB) per unit increase of the platelets/leukocyte ratio.

<p>This scatter plot shows the change of mtDNAcn(WB) per unit increase of the platelets/leukocyte ratio. Data from 46 preparations are shown. Individual mtDNAcn(WB) for each preparation are plotted as white circles. The line represents the fit of a linear model (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0163770#pone.0163770.t003" target="_blank">Table 3</a>, Model 6). mtDNAcn(WB): mitochondrial DNA copy number measured in whole blood.</p

Hematological results from primary blood samples (n = 10) that were used to derive blood preparations.

<p>Hematological results from primary blood samples (n = 10) that were used to derive blood preparations.</p

Platelet count, Leukocyte count and mtDNAcn(WB) distributions in all subjects from the AWHS cohort study (n = 3389).

<p>Platelet count, Leukocyte count and mtDNAcn(WB) distributions in all subjects from the AWHS cohort study (n = 3389).</p

Coefficients of multivariate regression models for mtDNAcn(WB) measured in blood preparations (n = 46).

<p>Coefficients of multivariate regression models for mtDNAcn(WB) measured in blood preparations (n = 46).</p

Characteristics of the study population with and without metabolic syndrome.

<p>Average and standard deviation of clinical, physical, and biochemical parameters. P values were calculated from t-tests.</p><p>*n = 3136 due to missing values.</p><p>^†BP: Blood Pressure.</p><p>^‡HOMA-IR: Homeostatic Model Assessment—Insulin Resistance.</p><p>Characteristics of the study population with and without metabolic syndrome.</p